BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12190885)

  • 1. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review.
    Ernst E
    J Intern Med; 2002 Aug; 252(2):107-13. PubMed ID: 12190885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong.
    Ching CK; Chen SPL; Lee HHC; Lam YH; Ng SW; Chen ML; Tang MHY; Chan SSS; Ng CWY; Cheung JWL; Chan TYC; Lau NKC; Chong YK; Mak TWL
    Br J Clin Pharmacol; 2018 Jan; 84(1):172-178. PubMed ID: 28965348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan.
    Huang WF; Wen KC; Hsiao ML
    J Clin Pharmacol; 1997 Apr; 37(4):344-50. PubMed ID: 9115061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid adulteration in proprietary Chinese medicines: a recurring problem.
    Chong YK; Ching CK; Ng SW; Mak TW
    Hong Kong Med J; 2015 Oct; 21(5):411-6. PubMed ID: 26314568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality control of Chinese herbal medicines with chromatographic fingerprints].
    Zhou J; Qi L; Li P
    Se Pu; 2008 Mar; 26(2):153-9. PubMed ID: 18581845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review on fingerprinting development to determine adulteration of Chinese herbal medicines.
    Luo Y; Yang H; Tao G
    Phytomedicine; 2024 Jul; 129():155667. PubMed ID: 38728918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong.
    Ching CK; Lam YH; Chan AY; Mak TW
    Br J Clin Pharmacol; 2012 May; 73(5):795-800. PubMed ID: 22034838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic speciation in Chinese Herbal Medicines and human health implication for inorganic arsenic.
    Liu XJ; Zhao QL; Sun GX; Williams P; Lu XJ; Cai JZ; Liu WJ
    Environ Pollut; 2013 Jan; 172():149-54. PubMed ID: 23063615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical methods for the detection of undeclared synthetic drugs in traditional herbal medicines as adulterants.
    Haneef J; Shaharyar M; Husain A; Rashid M; Mishra R; Siddique NA; Pal M
    Drug Test Anal; 2013 Aug; 5(8):607-13. PubMed ID: 23653249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.
    Posadzki P; Watson L; Ernst E
    Eur J Clin Pharmacol; 2013 Mar; 69(3):295-307. PubMed ID: 22843016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heavy metal pollution and potential health risks of commercially available Chinese herbal medicines.
    Wang Z; Wang H; Wang H; Li Q; Li Y
    Sci Total Environ; 2019 Feb; 653():748-757. PubMed ID: 30759600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review on randomized controlled trials of coronary heart disease complicated with depression treated with Chinese herbal medicines.
    Wang AL; Chen Z; Luo J; Shang QH; Xu H
    Chin J Integr Med; 2016 Jan; 22(1):56-66. PubMed ID: 26085199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky.
    Skalicka-Woźniak K; Georgiev MI; Orhan IE
    Food Chem Toxicol; 2017 Oct; 108(Pt B):355-364. PubMed ID: 27338710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of adverse reactions from contaminants in Chinese herbal medicines can be minimized by using quality products and qualified practitioners.
    Hohmann N; Koffler K
    Int J Environ Health Res; 2002 Mar; 12(1):99-100; author reply 101. PubMed ID: 11970820
    [No Abstract]   [Full Text] [Related]  

  • 15. Chinese herbal medicine for diabetic peripheral neuropathy.
    Chen W; Zhang Y; Li X; Yang G; Liu JP
    Cochrane Database Syst Rev; 2013 Oct; (10):CD007796. PubMed ID: 24096743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.
    Melchart D; Hager S; Dai J; Weidenhammer W
    Forsch Komplementmed; 2016; 23 Suppl 2():21-8. PubMed ID: 27272353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine for headache: A systematic review and meta-analysis of high-quality randomized controlled trials.
    Shi YH; Wang Y; Fu H; Xu Z; Zeng H; Zheng GQ
    Phytomedicine; 2019 Apr; 57():315-330. PubMed ID: 30807986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic heavy metals and undeclared drugs in Asian herbal medicines.
    Ernst E
    Trends Pharmacol Sci; 2002 Mar; 23(3):136-9. PubMed ID: 11879681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.
    Koh HL; Woo SO
    Drug Saf; 2000 Nov; 23(5):351-62. PubMed ID: 11085343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese herbal medicine for diabetic peripheral neuropathy.
    Chen W; Zhang Y; Liu JP
    Cochrane Database Syst Rev; 2011 Jun; (6):CD007796. PubMed ID: 21678369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.